Vident Advisory
AHCO icon

Vident Advisory’s AdaptHealth AHCO Stock Holding History

Vident Advisory’s Portfolio AHCO Stock Details AHCO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$868K Buy
83,282
+71,422
+602% +$797K 0.01% 1049
2026
Q1 		$141K Buy
+11,860
New +$121K ﹤0.01% 1764
2025
Q4 		– Sell
-11,480
Closed -$103K – 1634
2025
Q3 		$103K Sell
11,480
-6,257
-35% -$57.9K ﹤0.01% 1601
2025
Q2 		$167K Buy
17,737
+2,694
+18% +$23.8K ﹤0.01% 1524
2025
Q1 		$163K Buy
+15,043
New +$151K ﹤0.01% 1470

Other funds holding AHCO

OCA
OEP Capital Advisors New York $170M AUM 10.5% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Deerfield Management
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
SC
SkyKnight Capital San Francisco, California $94.1M AUM 10.85% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Reinhart Partners
Reinhart Partners Mequon, Wisconsin $4.11B AUM 38.38% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Vident Advisory's AHCO Position: Q2 2026 in Review

Vident Advisory increased its AdaptHealth (AHCO) stake by 602% in Q2 2026, buying an estimated $797K and bringing the position to 83,282 shares worth $868K. The position accounts for 0.01% of the portfolio, ranked #1049.

Vident Advisory first reported a position in AHCO in Q1 2025 and has held it in 5 quarters since. 239 funds tracked by Wall St. Rank hold AHCO as of Q2 2026.

  • Vident Advisory held 83,282 shares of AdaptHealth worth $868K as of Q2 2026.
  • Vident Advisory bought 71,422 AdaptHealth shares in Q2 2026, an estimated $797K.
  • AdaptHealth made up 0.01% of Vident Advisory's portfolio in Q2 2026, its #1049 holding.
  • Vident Advisory first reported a position in AdaptHealth in Q1 2025 and has held it in 5 quarters since.
  • 239 funds tracked by Wall St. Rank held AdaptHealth as of Q2 2026.

Based on Vident Advisory's 13F filing for Q2 2026, filed 12 Aug 2026.